Publications
Stevenson W, et al. Dry eye disease: an immune-mediated ocular surface disorder, Arch Ophthalmol. 2012;130(1):90-100. doi:10.1001/archophthalmol.2011.364
EBI-005 an Interleukin-1 Receptor Inhibitor Designed for the Treatment of Dry Eye Syndrome. ARVO May 7, 2012.
Media Contact:
Gina Nugent
The Yates Network
617-460-3579